DESCRIPTION (provided by applicant): Postabsorptive fuel metabolism is an important factor in the control of food intake. Sensors in brain and liver that are sensitive to various metabolic parameters have been implicated in this control. In liver, considerable evidence indicates that changes in energy metabolism produce a stimulus or stimuli that are transduced into a neural signal that carries this metabolic information to the central nervous system for use in controlling food intake. In particular, changes in hepatic ATP content, or some closely related change in liver energy status, generate signals that initiate or terminate feeding behavior under various conditions, such as fasting-refeeding, type I diabetes, and treatment with metabolic inhibitors. Recent studies in this laboratory have revealed that three different animal models of obesity (genetic, dietary and neurological) show reduced hepatic energy status, suggesting that changes in liver energy status are also involved in overeating and the development of obesity. The overall goal of this project is to assess whether and how altered hepatic energy metabolism is a contributing cause of hyperphagia (overeating) that leads to obesity. Some rats overeat and become obese when fed a diet high in fat content (obesity-prone), whereas others of the same strain do not (obesity-resistant). The proposed research will use this diet-induced animal model of obesity because it appears most comparable to the obesity commonly seen in humans. We hypothesize that, during the development of obesity, hyperphagia may be driven at least in part by decreased liver energy status, which is secondary to the redirection of fuels into storage and away from oxidative pathways. Overeating could result from a faster decline in hepatic energy status between meals or a slower recovery in hepatic energy status during and after a meal. The project has three specific aims: (1) Determine whether overeating in obesity prone rats is due to an enhanced susceptibility to reductions in liver energy status. (2) Determine whether overeating in obesity prone rats is due to a slow restoration of liver energy status. (3) Determine whether calcium signaling during metabolic stimulus transduction differs in hepatocytes from lean and obese rats.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
adenosine triphosphateantimetabolitesbehavior predictionbioenergeticscalcium fluxcarbohydrate analoglaboratory ratliver cellsliver metabolismmannitolnuclear magnetic resonance spectroscopynutrient intake activitynutrition related tagobesityouabainovereatingpsychobiologysodium potassium exchanging ATPase
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
848
DUNS Number
088812565
UEI
DJCTQA1PR7Q4
Project Start Date
01-August-1993
Project End Date
31-March-2006
Budget Start Date
01-April-2003
Budget End Date
31-March-2004
Project Funding Information for 2003
Total Funding
$304,857
Direct Costs
$210,000
Indirect Costs
$94,857
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Diabetes and Digestive and Kidney Diseases
$304,857
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01DK053109-09A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01DK053109-09A2
Patents
No Patents information available for 2R01DK053109-09A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01DK053109-09A2
Clinical Studies
No Clinical Studies information available for 2R01DK053109-09A2
News and More
Related News Releases
No news release information available for 2R01DK053109-09A2
History
No Historical information available for 2R01DK053109-09A2
Similar Projects
No Similar Projects information available for 2R01DK053109-09A2